Dr. Naomi O’Grady, MD, is an internationally recognized leader in the prevention of vascular catheter-related complications. A distinguished infectious disease physician, intensivist, and physician scientist, she brings to Onnix significant expertise in clinical trials, translational research, and FDA regulatory policies. Dr. O’Grady has authored pivotal research and a seminal review on the prevention of catheter related bloodstream infections in the New England Journal of Medicine, as well as serving as the lead author on the CDC’s 2002 and 2011 Guidelines for the Prevention of Intravascular Catheter-Related Infections—landmark publications that continue to define clinical practice across healthcare systems globally and establishing her as one of the most influential voices in the field. Dr. O’Grady is frequently invited to speak at national and international conferences where her insights continue to shape standards of care and prevention practices worldwide.

As the former Medical Director of the vascular access device service at the National Institutes of Health Clinical Center, Dr. O'Grady combines scientific rigor with extensive frontline clinical experience. Her longstanding commitment to advancing evidence-based infection prevention strategies, including the adoption of technologies that reduce reliance on the bedside variability of providers to improve patient safety, align directly with Onnix’s mission and the development of its innovative lock-flush solution. In her role as Chief Medical Officer at Onnix, Dr. O’Grady provides strategic clinical leadership grounded in years of expertise at the intersection of critical care medicine, infectious diseases, and vascular access device innovation.

Dr. O’Grady has previously served as the Chair of the ABIM Critical Care Medicine Specialty Board and has held positions on the ABIM Council and the ABIM Board of Directors. She is a Fellow of the Infectious Diseases Society of America and the of the American College of Critical Care Medicine.

Bringing a rare combination of clinical, regulatory, and guideline-setting expertise in vascular access and catheter care, she is uniquely positioned to lead ONNIX’s regulatory pathway, and clinical strategy and applications.